EcoDrugPlus

Histone Deacetylase 11

Ensembl ID : ENSBTAG00000007208
Gene Symbol: HDAC11
4 Enzyme and pathways 5 Cross references
210 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSBTAG00000011849
Gene Symbol: HDAC2
30 Enzyme and pathways 5 Cross references
213 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSBTAG00000017360
Gene Symbol: HDAC3
23 Enzyme and pathways 5 Cross references
168 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSBTAG00000017764
Gene Symbol: HDAC4
12 Enzyme and pathways 5 Cross references
275 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSBTAG00000016254
Gene Symbol: HDAC5
4 Enzyme and pathways 5 Cross references
206 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSBTAG00000013244
Gene Symbol: HDAC6
14 Enzyme and pathways 5 Cross references
195 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSBTAG00000026819
Gene Symbol: HDAC7
9 Enzyme and pathways 5 Cross references
275 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSBTAG00000046092
Gene Symbol: HDAC8
15 Enzyme and pathways 5 Cross references
216 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSBTAG00000003808
Gene Symbol: HDAC9
4 Enzyme and pathways 5 Cross references
247 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 2

Ensembl ID : ENSBTAG00000047904
Gene Symbol: LOC527744
7 Enzyme and pathways 4 Cross references
176 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSBTAG00000015086
Gene Symbol: HSD11B1
7 Enzyme and pathways 5 Cross references
279 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSBTAG00000017466
Gene Symbol: HCN4
3 Enzyme and pathways 5 Cross references
300 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).